Q Chip
Business profile
Location: south east Wales
Sector: pharmaceuticals
Web site: www.q-chip.com
Investment
First round: £250,000 (syndicated investment
with Fusion IP)
Second round: £320,000 (part of circa £1
million syndication with investors including Curzon Park
Capital)
Type: equity and convertible loan notes
Executive: Richard Thompson
Why we invested
Q Chip commercialised technology originally developed at Cardiff University. Its core
product is sustained-release drug-delivery for therapeutic
applications.
Q Chip displayed key attributes we look for in early stage
investments:
- Pioneering technology
- Strong IP
- Talented management team
The outcome
Q Chip used our investments to develop its core product and to
strengthen its sales and marketing channels.
Testimonials
"With this latest investment, Q Chip can accelerate development
of its proof-of-concept products and its sales and marketing
channels." Jo Macpherson, CSO and founder, Q Chip.
“The current £1 million syndicated investment round enables
Q-Chip to achieve key value adding milestones, making it a very
attractive offering to raise substantial investment.” Dr Richard
Thompson, early stage investments manager, Finance Wales.
"Q Chip is an example of the kind of high growth, knowledge-based
businesses that Finance Wales invests in. Our original investment
was our first syndicated investment with Fusion IP." Steve Smith,
head of early stage investments, Finance Wales.